EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-Metaanalyse

Treatments for Burning Mouth Syndrome: A Network Meta-analysis

R Alvarenga-Brant, F O Costa, G Mattos-Pereira iD, R P Esteves-Lima, F V Belém, H Lai, L Ge, R S Gomez, C C Martins iD

Journal of Dental Research · 2023-02 · 102 (2) · 135-145

DOI: 10.1177/00220345221130025 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Dental Research, online erschienen am 08.10.2022. Verfasst von R Alvarenga-Brant und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Dentistry, Pathology and Oral Surgery, Faculty of Dentistry, Federal University of Minas Gerais, Belo Horizonte, Brazil. Hauptthemen laut MEDLINE: Clonazepam, Burning Mouth Syndrome. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this systematic review and network meta-analysis (NMA) of randomized controlled trials was to evaluate the effectiveness of treatments for pain relief of burning mouth syndrome (BMS). Five databases and gray literature were searched. Independent reviewers selected studies, extracted data, and assessed the risk of bias. The primary outcome was pain relief or burning sensation, and the secondary outcomes were side effects, quality of life, salivary flow, and TNF-α and interleukin 6 levels. Four comparable interventions were grouped into different network geometries to ensure the transitivity assumption for pain: photobiomodulation therapy, alpha-lipoic acid, phytotherapics, and anxiolytics/antidepressants. Mean difference (MD) and 95% CI were calculated for continuous outcomes. The minimal important difference to consider a therapy beneficial against placebo was an MD of at least −1 for relief of pain. To interpret the results, the GRADE approach for NMA was used with a minimally contextualized framework and the magnitude of the effect. Forty-four trials were included (24 in the NMA). The anxiolytic (clonazepam) probably reduces the pain of BMS when compared with placebo (MD, −1.88; 95% CI, −2.61 to −1.16; moderate certainty). Photobiomodulation therapy (MD, −1.90; 95% CI, −3.58 to −0.21) and pregabalin (MD, −2.40; 95% CI, −3.49 to −1.32) achieved the minimal important difference of a beneficial effect with low or very low certainty. Among all tested treatments, only clonazepam is likely to reduce the pain of BMS when compared with placebo. The majority of the other treatments had low and very low certainty, mainly due to imprecision, indirectness, and intransitivity. More randomized controlled trials comparing treatments against placebo are encouraged to confirm the evidence and test possible alternative treatments (PROSPERO CRD42021255039).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClonazepamBurning Mouth SyndromeHumansQuality of LifePain

Stichwörter der Autor:innen

anti-anxiety agentsclonazepaminterventional studiesmouth diseasespsychophysiologic disordersstomatognathic diseases

Substanzen

Clonazepam

Autor:innen und Institutionen

  • Department of Clinical Dentistry, Pathology and Oral Surgery, Faculty of Dentistry, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Department of Periodontology, Faculty of Dentistry, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Department of Pediatric Dentistry, Faculty of Dentistry, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China.

ORCID-Profile: G Mattos-Pereira, C C Martins

Förderung

  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Alvarenga-Brant, R., Costa, F. O., Mattos-Pereira, G., Esteves-Lima, R. P., Belém, F. V., Lai, H., Ge, L., Gomez, R. S., & Martins, C. C. (2023). Treatments for Burning Mouth Syndrome: A Network Meta-analysis. Journal of Dental Research, 102(2), 135-145. https://doi.org/10.1177/00220345221130025

Vancouver

Alvarenga-Brant R, Costa FO, Mattos-Pereira G, Esteves-Lima RP, Belém FV, Lai H, et al. Treatments for Burning Mouth Syndrome: A Network Meta-analysis. Journal of Dental Research. 2023;102(2):135-145. doi:10.1177/00220345221130025

BibTeX
@article{AlvarengaBrant2023,
  author = {Alvarenga-Brant, R and Costa, F O and Mattos-Pereira, G and Esteves-Lima, R P and Belém, F V and Lai, H and Ge, L and Gomez, R S and Martins, C C},
  title = {Treatments for Burning Mouth Syndrome: A Network Meta-analysis},
  journal = {Journal of Dental Research},
  year = {2023},
  volume = {102},
  number = {2},
  pages = {135--145},
  doi = {10.1177/00220345221130025}
}
Kostenlos starten →